cefixime has been researched along with amoxicillin in 97 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (16.49) | 18.7374 |
1990's | 42 (43.30) | 18.2507 |
2000's | 17 (17.53) | 29.6817 |
2010's | 17 (17.53) | 24.3611 |
2020's | 5 (5.15) | 2.80 |
Authors | Studies |
---|---|
Hirose, T; Kumamoto, Y; Nishimura, M; Ohya, S; Shibuya, A; Tsukamoto, T | 1 |
Chiba, N; Hunt, RH; Rademaker, JW; Rao, BV | 1 |
Bingen, E; Bourgeois, F; Chardon, H; Doit, C; Lambert-Zechovsky, N | 1 |
Hatakeyama, K; Hori, M; Nakano, K; Sakaguchi, N; Sugita, M; Toyonaga, Y; Yamazaki, M; Yamori, K | 1 |
Arguedas, AG; Stutman, HR | 1 |
Marchisio, P; Principi, N | 1 |
Carlin, SA; Johnson, CE; Marchant, CD; Shurin, PA | 1 |
Clausen, CR; Del Beccaro, MA; Duncan, NO; Inglis, AF; Mendelman, PM; Richardson, MA; Stull, TL | 1 |
Allen, SD; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Pfaller, MA; Washington, JA | 1 |
Flanagan, C; Nash, DR; Steele, LC; Wallace, RJ | 1 |
Carlin, SA; Christopher, NC; Johnson, CE; Rehmus, JM; Roberts, DG; Shurin, PA; Super, DM; Whitwell, JK | 1 |
Bowie, WR; Lefebvre, K; Megran, DW; Willetts, V | 1 |
Chonmaitree, T; Howie, VM; Owen, MJ | 1 |
Bellon, O; Chardon, H; Giraud, E; Lagier, E | 1 |
Hugues, FC; Le Jeunne, C | 1 |
Beumer, HM | 1 |
Leigh, AP; Millar, ED; Robinson, D | 1 |
Bryant, A; Iravani, A; Johnson, D; Richard, GA | 1 |
Johnson, D; Kiani, R; Nelson, B | 1 |
Baugher, LK; Counts, GW; Hamilton, DJ; Ulness, BK | 1 |
Lin, SR; Peng, CF | 1 |
Chin, NX; Neu, HC | 1 |
McLinn, SE | 1 |
Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
Howie, VM; Owen, MJ | 1 |
Chin, NX; Labthavikul, P; Neu, HC | 1 |
Fujishita, Y; Kaizu, M; Kojo, H; Matsumoto, Y; Shigi, Y | 1 |
Goto, S; Kamimura, T; Kojo, H; Kuwahara, S; Matsumoto, Y; Mine, Y | 1 |
Allen, S; Barry, A; Fuchs, P; McLaughlin, J; Pfaller, M; Sewell, D | 1 |
Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
Bost, C; Croizé, J; François, P; Wollschlager, K | 1 |
Lieberman, D; Schlaeffer, F | 1 |
Kafetzis, DA | 1 |
Garcia Iglesias, MC; Perea, EJ | 1 |
Baquero, F; Loza, E; Morosini, MI; Negri, MC | 1 |
Livermore, DM; Yeo, SF | 1 |
Friedland, IR | 1 |
Hefelfinger, DC | 1 |
Berman, S; Roark, R | 1 |
Anwar, R; Bannister, ER; Howie, VM; Nguyen, HK; Owen, MJ; Swank, PR | 1 |
Avner, SE; Bierman, WC; Chow, JM; Duerksen, RL; Edelstein, DR; Johnson, J; Kohlbrenner, VM; Matthews, BL; Ronis, M; Rybak, LP | 1 |
Bégué, P; Boulesteix, J; Dabernat, H; de La Rocque, F; Dubreuil, C; Geslin, P; Mégraud, F; Trinh, A | 1 |
Liston, TE | 1 |
Beghi, GF; Casalini, A; Cazzola, M; Consigli, GF; Fiorentini, F; Giura, R; Madonini, V; Paizis, G; Tonna, M; Vinciguerra, A | 1 |
Amir, J; Eidlitz-Markus, T; Harel, L; Varsano, I | 1 |
Gooch, WM; Philips, A; Rhoades, R; Rosenberg, R; Schaten, R; Starobin, S | 1 |
Goldstein, FW | 1 |
Bajaksouzian, S; Jacobs, MR | 1 |
Verbist, L; Verhaegen, J | 1 |
Johnson, DM; Jones, RN | 1 |
Matsumoto, Y | 1 |
García-Rodríguez, JA | 1 |
Almela, M; García San Miguel, J; Marco, F; Martínez, JA; Mensa, J; Moreno-Martínez, A; Soriano, E; Vila, J | 1 |
Nikoskelainen, J; Oksi, J; Viljanen, MK | 1 |
Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
Joshi, VR; Mehta, A; Rodrigues, C | 1 |
Amores, R; Calvo, A; Prieto, J; Sevillano, D; Valero, E | 1 |
Bachor, J; Dinari, G; Fishman, M; Gal, E; Geler, A; Niv, Y; Passaro, DJ; Samra, Z; Shmuely, H; Yahav, J | 1 |
Blatto, M; Filiberti, G; Grasso, R; Marchisio, P; Principi, N | 1 |
Furuya, R; Iyoda, T; Kanayama, A; Kobayashi, I; Matsuzaki, K; Nakayama, H; Saika, T; Tanaka, M; Tatewaki, M | 1 |
Egawa, S; Endo, K; Hosobe, T; Kiyota, H; Kobayashi, I; Onodera, S; Suzuki, H; Takahashi, T | 1 |
Bröcker, EB; Gross, GE; Seitz, CS; Trautmann, A; Trcka, J | 1 |
Bachiller Luque, MR; Eiros Bouza, JM; Pastor García, E; Vázquez Fernández, ME; Vázquez Fernández, MJ | 1 |
Ghosh, TK | 1 |
Chen, J; He, J; Miao, X; Wu, X; Xie, Y; Xu, B; Xu, M; Yu, L; Zhang, W | 1 |
Adriani, A; Astegiano, M; Pellicano, R; Rizzetto, M; Smedile, A | 1 |
Barni, S; Mori, F; Novembre, E; Pucci, N | 1 |
Bala, S; Kajal, A; Kamboj, S; Prasad, DN; Saini, V | 1 |
Cutović, T; Daković, D; Dukić, S; Matijević, S | 1 |
Comunián-Carrasco, G; Martí-Carvajal, AJ; Peña-Martí, GE | 1 |
Chaudhry, GE; Perveen, S; Safdar, N; Yasmin, A | 1 |
Abdollahi, M; Dinarvand, R; Hosseini, M; Kebriaeezade, A; Rashidian, A; Soleymani, F | 1 |
Basu, T; Das, R; Kumar, R; Mehrotra, T; Rao R, P; Roy, I; Sharma, S; Singh, R | 1 |
Asadi Karam, MR; Bouzari, S; Moazzezy, N; Oloomi, M; Rafati, S | 1 |
Adeoye, F; Amosun, E; Kolapo, A; Oladele, O; Olatoye, O | 1 |
Chen, Q; Chen, Y; Huang, X; Ji, X; Lin, Z; Suo, B; Wu, B; Zheng, X; Zhou, X | 1 |
Pınarbaşı, AS; Samanci, S | 1 |
Clauss, W; Daniel, H; Gebert, I; Weber, WM; Weintraut, H; Wenzel, U | 1 |
Inui, K; Mukai, M; Saito, H; Terada, T | 1 |
Brandsch, M; Luckner, P | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Aracil, B; Campos, J; Carrera, C; García-Cobos, S; Oteo, J; Pérez-Vázquez, M; Román, F | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Campos, J; Carrilero, L; Escudero, JA; Garcia-Cobos, S; Gonzalez-Zorn, B; Gutierrez, B; Hidalgo, L; San Millan, A | 1 |
Al-Qawasmeh, RA; Al-Tel, TH | 1 |
Al-Qawasmeh, RA; Al-Tel, TH; Zaarour, R | 1 |
Aldini, G; De Luca, L; Marconi, C; Pedretti, A; Regazzoni, L; Vistoli, G | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
10 review(s) available for cefixime and amoxicillin
Article | Year |
---|---|
Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Cefixime; Cefotaxime; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Research Design; Sensitivity and Specificity | 1992 |
Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Humans; Infant; Otitis Media with Effusion | 1992 |
[In vitro effect of cefixime against 200 strains of Branhamella catarrhalis. Comparison with cefotaxime].
Topics: Amoxicillin; beta-Lactamases; Cefixime; Cefotaxime; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic | 1989 |
Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections.
Topics: Amoxicillin; Cefixime; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Random Allocation; Respiratory Tract Infections | 1988 |
Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Multicenter Studies as Topic; Otitis Media; Randomized Controlled Trials as Topic | 1994 |
Cefixime therapy for otitis media.
Topics: Acute Disease; Amoxicillin; Anti-Infective Agents; Cefixime; Cefotaxime; Humans; Otitis Media with Effusion; Pneumococcal Infections; Treatment Failure | 1993 |
Once-a-day therapy for sinusitis: a comparison study of cefixime and amoxicillin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Capsules; Cefixime; Cefotaxime; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prospective Studies; Remission Induction; Sinusitis; Time Factors | 1993 |
Management of otitis media. A review.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Child; Humans; Otitis Media; Penicillins; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
Antibiotics for treating gonorrhoea in pregnancy.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Female; Gonorrhea; Humans; Pregnancy; Pregnancy Complications, Infectious; Probenecid; Randomized Controlled Trials as Topic; Spectinomycin | 2018 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
30 trial(s) available for cefixime and amoxicillin
Article | Year |
---|---|
[Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Microbial Sensitivity Tests | 1992 |
Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Humans; Infant; Otitis Media with Effusion | 1992 |
Cefixime vs amoxicillin in the treatment of acute otitis media in infants and children.
Topics: Acute Disease; Amoxicillin; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Otitis Media | 1991 |
Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon".
Topics: Acute Disease; Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefaclor; Cefixime; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Double-Blind Method; Drug Combinations; Efficiency; Enzyme Inhibitors; Female; Haemophilus influenzae; Humans; Infant; Male; Moraxella catarrhalis; Otitis Media; Punctures; Streptococcus pneumoniae; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Tympanic Membrane | 1992 |
Bacteriology of acute otitis media: a new perspective.
Topics: Acute Disease; Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteria; Bacteriological Techniques; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Haemophilus influenzae; Humans; Infant; Moraxella catarrhalis; Otitis Media; Prodrugs; Punctures; Recurrence; Single-Blind Method; Streptococcus pneumoniae; Tympanic Membrane | 1992 |
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolates.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Staphylococcus; Streptococcus agalactiae | 1991 |
Cefixime compared with amoxicillin for treatment of acute otitis media.
Topics: Acute Disease; Adolescent; Amoxicillin; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Haemophilus influenzae; Humans; Infant; Male; Moraxella catarrhalis; Otitis Media; Streptococcus pneumoniae | 1991 |
Single-dose oral cefixime versus amoxicillin plus probenecid for the treatment of uncomplicated gonorrhea in men.
Topics: Adolescent; Adult; Amoxicillin; Cefixime; Cefotaxime; Gonorrhea; Humans; Male; Probenecid; Randomized Controlled Trials as Topic; Urethritis | 1990 |
Respiratory viruses interfere with bacteriologic response to antibiotic in children with acute otitis media.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Male; Otitis Media with Effusion; Prospective Studies; Random Allocation; Virus Diseases | 1990 |
[In vitro effect of cefixime against 200 strains of Branhamella catarrhalis. Comparison with cefotaxime].
Topics: Amoxicillin; beta-Lactamases; Cefixime; Cefotaxime; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic | 1989 |
[Controlled multicentric study comparing cefixime and amoxicillin in the treatment of lower respiratory tract infections in adults].
Topics: Adolescent; Adult; Aged; Amoxicillin; Cefixime; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multicenter Studies as Topic; Random Allocation; Respiratory Tract Infections | 1989 |
Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
Topics: Adult; Amoxicillin; Bacterial Infections; Cefixime; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections | 1989 |
A general practice comparative study of a new third-generation oral cephalosporin, cefixime, with amoxycillin in the treatment of acute paediatric otitis media.
Topics: Acute Disease; Adolescent; Amoxicillin; Cefixime; Cefotaxime; Child; Child, Preschool; Family Practice; Female; Humans; Infant; Male; Multicenter Studies as Topic; Otitis Media; Random Allocation | 1989 |
A double-blind, multicenter, comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of acute urinary tract infections in adult patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Amoxicillin; Cefixime; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Random Allocation; Urinary Tract Infections | 1988 |
Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections.
Topics: Amoxicillin; Cefixime; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Random Allocation; Respiratory Tract Infections | 1988 |
Randomized, open label, multicenter trial of cefixime compared with amoxicillin for treatment of acute otitis media with effusion.
Topics: Acute Disease; Amoxicillin; Cefixime; Cefotaxime; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Infant; Male; Otitis Media with Effusion; Random Allocation | 1987 |
[Comparative study of cefixime versus amoxicillin-clavulanic acid combination in the oral treatment of urinary tract infections in children].
Topics: Administration, Oral; Adolescent; Amoxicillin; Anti-Bacterial Agents; Cefixime; Cefotaxime; Child; Child, Preschool; Clavulanic Acids; Drug Combinations; Drug Tolerance; Female; Humans; Infant; Male; Prospective Studies; Urinary Tract Infections | 1995 |
Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Multicenter Studies as Topic; Otitis Media; Randomized Controlled Trials as Topic | 1994 |
Factors influencing outcome in children treated with antibiotics for acute otitis media.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Infant; Male; Otitis Media; Regression Analysis; Risk Factors; Treatment Outcome | 1993 |
Efficacy of cefixime in the treatment of acute otitis media in children.
Topics: Acute Disease; Administration, Oral; Amoxicillin; Anti-Infective Agents; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Hospitals, University; Humans; Infant; Male; Otitis Media; Outpatient Clinics, Hospital; Patient Compliance; Texas; Treatment Outcome | 1993 |
Once-a-day therapy for sinusitis: a comparison study of cefixime and amoxicillin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Capsules; Cefixime; Cefotaxime; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prospective Studies; Remission Induction; Sinusitis; Time Factors | 1993 |
Acute otitis media in children: a study of nasopharyngeal carriage of potential pathogens and therapeutic efficacy of cefixime and amoxicillin-clavulanate.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteria; Cefixime; Cefotaxime; Cephalosporins; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Humans; Infant; Nasopharynx; Otitis Media | 1995 |
Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bronchitis; Cefixime; Cefotaxime; Chronic Disease; Ciprofloxacin; Clavulanic Acids; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 1995 |
Comparative evaluation of cefixime versus amoxicillin-clavulanate following ceftriaxone therapy of pneumonia.
Topics: Administration, Oral; Amoxicillin; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Penicillins; Pneumonia, Pneumococcal; Radiography | 1996 |
Comparison of the efficacy, safety and acceptability of cefixime and amoxicillin/clavulanate in acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media; Prospective Studies; Treatment Outcome | 1997 |
[Cefixime versus amoxicillin plus netilmicin in the treatment of community-acquired non-complicated acute pyelonephritis].
Topics: Acute Disease; Adult; Aged; Amoxicillin; Bacteremia; Cefixime; Cefotaxime; Cephalosporins; Communicable Diseases; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Netilmicin; Pyelonephritis | 1998 |
Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis.
Topics: Administration, Oral; Adult; Amoxicillin; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Administration Schedule; Drug Therapy, Combination; Humans; Injections, Intravenous; Lyme Disease; Penicillins; Probenecid; Renal Agents; Treatment Outcome | 1998 |
Aminopenicillin-induced exanthema allows treatment with certain cephalosporins or phenoxymethyl penicillin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefixime; Cefpodoxime; Ceftizoxime; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Exanthema; Female; Humans; Hypersensitivity, Delayed; Immunoglobulin E; Male; Middle Aged; Penicillin V; Single-Blind Method; Skin Tests; Treatment Outcome | 2007 |
Comparison of cefixime and amoxicillin plus metronidazole in the treatment of chronic periodontitis.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Chronic Periodontitis; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Periodontal Index; Treatment Outcome | 2016 |
Effectiveness of audit and feedback in addressing over prescribing of antibiotics and injectable medicines in a middle-income country: an RCT.
Topics: Administration, Oral; Ambulatory Care; Amoxicillin; Anti-Bacterial Agents; Cefixime; Dexamethasone; Female; General Practitioners; Humans; Inappropriate Prescribing; Injections; Iran; Male; Medical Audit; Outcome Assessment, Health Care; Pediatricians; Program Evaluation; Socioeconomic Factors | 2019 |
62 other study(ies) available for cefixime and amoxicillin
Article | Year |
---|---|
[A clinical study on postantibiotic effect (PAE) and its application to chemotherapy for complicated cystitis with an automatic simulator of urinary drug concentration].
Topics: Amoxicillin; Anti-Infective Agents, Urinary; Automation; Cefixime; Cefotaxime; Cystitis; Enterobacter cloacae; Humans; Models, Biological; Ofloxacin; Staphylococcus epidermidis; Urinary Bladder | 1992 |
Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Child; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis | 1992 |
Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae.
Topics: Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythromycin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Tetracycline | 1991 |
Comparative in vitro activity of the new oral cephalosporin cefixime.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cefixime; Cefotaxime; Clavulanic Acids; Drug Resistance, Microbial; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella pneumoniae; Salmonella typhi | 1988 |
In vitro antibacterial activity of cefixime.
Topics: Amoxicillin; Ampicillin; Bacteria; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Humans; Microbial Sensitivity Tests | 1988 |
In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalexin; Cephalosporins; Clavulanic Acids; Culture Media; Drug Combinations; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria.
Topics: Amoxicillin; beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalexin; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Escherichia coli; In Vitro Techniques; Pseudomonas; Staphylococcus | 1986 |
Bacteriologic and clinical efficacy of cefixime compared with amoxicillin in acute otitis media.
Topics: Acute Disease; Amoxicillin; Bacteria; Cefixime; Cefotaxime; Humans; Microbial Sensitivity Tests; Otitis Media with Effusion; Patient Compliance | 1987 |
Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporin.
Topics: Amoxicillin; Bacteria; Bacteria, Anaerobic; beta-Lactamases; Cefixime; Cephalosporins; Humans; Hydrolysis; Microbial Sensitivity Tests | 1984 |
Mechanism of action of the new orally active cephalosporin FK027.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefaclor; Cefixime; Cephalexin; Cephalosporins; Enterobacter; Escherichia coli; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcus aureus | 1984 |
In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic.
Topics: Amoxicillin; Animals; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Cefaclor; Cefixime; Cephalexin; Cephalosporins; Mice; Penicillin Resistance | 1984 |
Comparative antimicrobial activities of the penem WY-49605 (SUN5555) against recent clinical isolates from five U.S. medical centers.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Carbapenems; Cefaclor; Cefixime; Cefotaxime; Clavulanic Acids; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; United States | 1995 |
In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cef
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Carbapenems; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance | 1994 |
Once-a-day cefixime versus co-amoxiclav three times daily in the treatment of lower respiratory infections.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefixime; Cefotaxime; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Respiratory Tract Infections; Sputum | 1995 |
Comparative in-vitro activity of cefdinir against multiresistant Haemophilus influenzae.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; beta-Lactamases; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Resistance, Multiple; Haemophilus influenzae; Kinetics; Microbial Sensitivity Tests | 1994 |
In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Cefotaxime; Cefuroxime; Culture Media; Microbial Sensitivity Tests; Models, Biological; Penicillin Resistance; Streptococcus pneumoniae | 1994 |
Effect of inoculum size on the in-vitro susceptibility to beta-lactam antibiotics of Moraxella catarrhalis isolates of different beta-lactamase types.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Ceftizoxime; Clavulanic Acids; Colony Count, Microbial; Drug Therapy, Combination; Microbial Sensitivity Tests; Moraxella catarrhalis | 1994 |
Cefixime therapy for otitis media.
Topics: Acute Disease; Amoxicillin; Anti-Infective Agents; Cefixime; Cefotaxime; Child; Chronic Disease; Humans; Otitis Media | 1993 |
Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae.
Topics: Administration, Oral; Amoxicillin; beta-Lactam Resistance; Cefaclor; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Protein Binding; Streptococcus pneumoniae | 1997 |
Evaluation of Haemophilus influenzae isolates with elevated MICs to amoxicillin/clavulanic acid.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteriological Techniques; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Culture Media; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Osmolar Concentration; Penicillins | 1997 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae | 1998 |
Combinations of orally administered beta-lactams to maximize spectrum and activity against drug-resistant respiratory tract pathogens: I. Synergy studies of amoxicillin and cefixime with Streptococcus pneumoniae.
Topics: Administration, Oral; Amoxicillin; Cefixime; Cefotaxime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Respiratory System; Streptococcus pneumoniae | 1998 |
Combination cefixime/amoxicillin against penicillin-resistant Streptococcus pneumoniae infection.
Topics: Amoxicillin; Animals; Cefixime; Cefotaxime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Humans; Mice; Penicillin Resistance; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 1998 |
Bacteriological comparison of cefixime in patients with noncomplicated urinary tract infection in Spain. Preliminary results.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Resistance, Microbial; Escherichia coli; Humans; Penicillins; Spain; Urinary Tract Infections | 1998 |
Clinical role of cefixime in community-acquired infections.
Topics: Administration, Oral; Amoxicillin; Cefixime; Cefotaxime; Cephalosporins; Drug Administration Schedule; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Infusions, Intravenous; Treatment Outcome | 1998 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
Salmonella typhiin the past decade: learning to live with resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Salmonella typhi; Typhoid Fever | 2002 |
[Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefixime; Cefpodoxime; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acid; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Spain; Streptococcus pneumoniae | 2001 |
Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime.
Topics: Amoxicillin; Cefixime; Chi-Square Distribution; Clarithromycin; Confidence Intervals; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline | 2002 |
Cefixime versus amoxicillin in the treatment of acute otitis media in infants and children.
Topics: Acute Disease; Amoxicillin; Cefixime; Child; Child, Preschool; Controlled Clinical Trials as Topic; Female; Humans; Infant; Infant, Newborn; Male; Otitis Media | 1989 |
In vitro synergistic effects of double combinations of beta-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Cefixime; Cefmenoxime; Drug Synergism; Humans; Male; Neisseria gonorrhoeae | 2006 |
Enhancement of antimicrobial activities of cefteram or clavulanic acid/amoxicillin against cefixime-resistant Neisseria gonorrhoeae in the presence of clarithromycin or azithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Cefixime; Cefmenoxime; Clarithromycin; Clavulanic Acid; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Humans; Male; Neisseria gonorrhoeae | 2006 |
[Variability in antibiotic prescription in the pediatric population of Castile and Leon (Spain) from 2001 to 2005 in relation to urban or rural setting].
Topics: Age Factors; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefixime; Child; Drug Prescriptions; Humans; Models, Theoretical; Primary Health Care; Rural Population; Spain; Urban Population | 2007 |
Cephalosporins with clavulinic acid.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Cefixime; Cefpodoxime; Ceftizoxime; Clavulanic Acid; Drug Therapy, Combination; Humans | 2009 |
Antimicrobial resistance and prevalence of resistance genes of obligate anaerobes isolated from periodontal abscesses.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Proteins; Bacteriological Techniques; Bacteroidaceae Infections; beta-Lactam Resistance; beta-Lactamases; Cefixime; Cephradine; Clindamycin; Doxycycline; Drug Resistance, Bacterial; Female; Genes, Bacterial; Humans; Imipenem; Male; Methyltransferases; Metronidazole; Middle Aged; Periodontal Abscess; Prevotella; Roxithromycin; Tetracycline Resistance | 2014 |
Efficacy of cefixime plus metronidazole therapy for Helicobacter pylori eradication: a retrospective study.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Cefixime; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome | 2013 |
Drug-induced enterocolitis syndrome (DIES).
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Child; Dairy Products; Diarrhea; Drug Eruptions; Drug Hypersensitivity; Enterocolitis; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydrocortisone; Skin Tests; Syndrome; Vomiting | 2014 |
1,3,4-oxadiazole derivatives: synthesis, characterization, antimicrobial potential, and computational studies.
Topics: Amidohydrolases; Amino Acids; Amoxicillin; Anti-Infective Agents; Bacteria; Catalytic Domain; Cefixime; Microbial Sensitivity Tests; Oxadiazoles | 2014 |
Antibacterial evaluation of silver nanoparticles synthesized from lychee peel: individual versus antibiotic conjugated effects.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Cell Membrane; Fruit; Gram-Negative Bacteria; Gram-Positive Bacteria; Litchi; Metal Nanoparticles; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Particle Size; Plant Extracts; Silver; Spectrum Analysis; Streptomycin; X-Ray Diffraction | 2018 |
Rapid Electrochemical Monitoring of Bacterial Respiration for Gram-Positive and Gram-Negative Microbes: Potential Application in Antimicrobial Susceptibility Testing.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacillus subtilis; Cefixime; Ciprofloxacin; Electrochemical Techniques; Escherichia coli; Microbial Sensitivity Tests; Time Factors | 2020 |
Inhibition and eradication activity of truncated α-defensin analogs against multidrug resistant uropathogenic Escherichia coli biofilm.
Topics: alpha-Defensins; Amoxicillin; Anti-Bacterial Agents; Biofilms; Cefixime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Norfloxacin; Uropathogenic Escherichia coli | 2020 |
Escherichia coli O157:H7 and Salmonella species Isolated from Ducks and Indigenous chickens in live-bird Markets in Ibadan, Oyo State, Nigeria.
Topics: Agar; Amoxicillin; Animals; Anti-Infective Agents; Cefixime; Ceftazidime; Cefuroxime; Chickens; Ducks; Escherichia coli O157; Gentamicins; Nigeria; Salmonella | 2022 |
Antibiotic resistance profile of
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Clarithromycin; Doxycycline; Drug Resistance, Bacterial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2023 |
Microbial etiology and antibiotic resistance in urinary tract infections in children; view from an area where antibiotics are overused.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefixime; Child; Child, Preschool; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Infant; Infant, Newborn; Male; Nitrofurantoin; Retrospective Studies; Urinary Tract Infections | 2023 |
Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells.
Topics: Animals; Biological Transport; Caco-2 Cells; Carrier Proteins; Cephalosporins; Humans; Hydrogen-Ion Concentration; Membrane Potentials; Oocytes; Peptide Transporter 1; Rabbits; Symporters; Xenopus laevis | 1996 |
Recognition of beta-lactam antibiotics by rat peptide transporters, PEPT1 and PEPT2, in LLC-PK1 cells.
Topics: Animals; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Ceftibuten; Cephalosporins; Cyclacillin; Dipeptides; Hydrogen-Ion Concentration; Kidney; Kinetics; LLC-PK1 Cells; Peptide Transporter 1; Rats; Recombinant Proteins; Structure-Activity Relationship; Symporters; Transfection | 1997 |
Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Binding Sites; Caco-2 Cells; Dose-Response Relationship, Drug; Humans; Peptide Transporter 1; Protein Binding; Rats; Symporters | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Low beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains are best detected by testing amoxicillin susceptibility by the broth microdilution method.
Topics: Amino Acid Substitution; Amoxicillin; Ampicillin Resistance; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Disk Diffusion Antimicrobial Tests; Genes, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Mutation; Penicillin-Binding Proteins; Phenotype | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Haemophilus influenzae clinical isolates with plasmid pB1000 bearing blaROB-1: fitness cost and interspecies dissemination.
Topics: Animals; beta-Lactamases; Cefaclor; Conjugation, Genetic; Drug Resistance, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Molecular Epidemiology; Molecular Sequence Data; Pasteurella multocida; Plasmids; Replicon; Spain; Species Specificity; Transformation, Genetic | 2010 |
Post Groebke-Blackburn multicomponent protocol: synthesis of new polyfunctional imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrimidine derivatives as potential antimicrobial agents.
Topics: Anti-Bacterial Agents; Cell Proliferation; Gram-Negative Bacteria; Gram-Positive Bacteria; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Pyridines; Pyrimidines; Stereoisomerism; Structure-Activity Relationship | 2010 |
Design, synthesis and in vitro antimicrobial evaluation of novel Imidazo[1,2-a]pyridine and imidazo[2,1-b][1,3]benzothiazole motifs.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Benzothiazoles; Dose-Response Relationship, Drug; Drug Design; Fungi; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Pyridines; Stereoisomerism; Structure-Activity Relationship | 2011 |
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
Topics: Binding Sites; Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Peptides; Protein Binding; Structural Homology, Protein; Symporters | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |